SIST EN ISO 11135:2014/A1:2020 PDF
Sterilization of health-care products - Ethylene oxide - Requirements for the development, validation and routine control of a sterilization process for medical devices - Amendment 1: Revision of Annex E, Single batch release (ISO 11135:2014/Amd 1:2018)
Sterilization of health-care products - Ethylene oxide - Requirements for the development, validation and routine control of a sterilization process for medical devices - Amendment 1: Revision of Annex E, Single batch release (ISO 11135:2014/Amd 1:2018)
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 22
- Дата публикации:
- 13 января 2020 г.
- ICS:
- 11.080.01
- Технический комитет:
- VAZ - Healthcare
20191119 - Negative assessment addressed through BT decision C168/2019 (SV) 2019-03-07-JO- under HAS assessment at PUB stage. E&Y Report was due on 03 March 2019. Awaiting for assessement report from E&Y. 2018-10-17 - TAN : Lack of compliance
Abstract
Overview
SIST EN ISO 11135:2014/A1:2020 is an amendment to the core standard EN ISO 11135:2014, detailing the requirements for the development, validation, and routine control of ethylene oxide sterilization processes for medical devices. Specifically, Amendment 1 revises Annex E, providing updated procedures and requirements for single batch release-essential for situations such as research, development, clinical trials, and limited production runs where only a single sterilization batch is available.
The standard is crucial for manufacturers and quality assurance professionals in the medical device industry who must ensure that devices are effectively sterilized with ethylene oxide (EO), especially in cases where standard validation procedures cannot be applied to large production runs.
Key Topics
- Single Batch Release: The amendment clarifies the application of single batch release specifically for new products, clinical trials, and cases with limited batch size. Using this approach for routine multiple batch release is only permissible as part of a full validation.
- Product Family Assessment: Requirements have been set for determining whether a new product can be classified within an existing product family for sterilization, considering product composition, design, packaging, bioburden, and load density.
- Sampling and Testing: Procedures for selecting representative samples from the manufacturing batch include bioburden assessment, use of biological indicators (BIs), process challenge devices (PCDs), product sterility testing, and other appropriate product tests.
- Sensor Use: Temperature and relative humidity sensors must be used to establish the environmental conditions within the sterilization load, ensuring the efficacy and uniformity of the process.
- Documentation: All assessments, rationale, test outcomes, and process parameters must be meticulously documented to comply with regulatory requirements and traceability standards.
Applications
This amendment to ISO 11135 provides practical value for:
- Medical device manufacturers: Enables effective sterilization control and compliance during development and clinical testing, especially when limited quantities are available.
- Quality assurance/validation teams: Provides clear steps for achieving compliance in non-standard sterilization scenarios, supporting the release of batches when full-scale validation is impractical.
- Regulatory submission: Supports conformity with essential requirements under EU Medical Device legislation by stipulating how products subjected to EO sterilization meet safety and performance expectations, even in small or unique production runs.
- Contract sterilization providers: Delivers standardized methods for documenting and justifying single batch releases, improving client confidence and audit readiness.
Related Standards
Compliance with SIST EN ISO 11135:2014/A1:2020 often involves consideration of related standards, including:
- ISO 11135:2014: The primary standard for EO sterilization process development, validation, and control.
- ISO 11138-1 and ISO 11138-2: Requirements for biological indicators used in EO sterilization validation.
- ISO 11737-1 and ISO 11737-2: Microbiological testing for bioburden determination and sterility testing of medical devices.
- ISO 10993-7: Guidance for ethylene oxide residuals in medical devices.
- EN ISO 13485: Quality management systems for medical devices.
- Relevant EU directives and regulations: Addresses essential safety and performance requirements under the Medical Devices Regulation (EU 2017/745), In Vitro Diagnostic Regulation (EU 2017/746), and related Directives 90/385/EEC, 93/42/EEC, and 98/79/EC.
Practical Value
By adhering to SIST EN ISO 11135:2014/A1:2020, organizations ensure:
- Effective, compliant release of medical devices sterilized in small or unique batches.
- Increased patient safety through rigorous and transparent sterilization validation.
- Streamlined regulatory approval for innovative or limited-release medical devices.
Key SEO Keywords: ethylene oxide sterilization, single batch release, medical devices, ISO 11135, validation, routine control, sterilization process, health-care products, EU medical device regulation.
Технические детали
- SKU
- SIST EN ISO 11135:2014/A1:2020
Похожие стандарты
Стандарты, упомянутые в описании
ISO 11135:2014
ДействующийSterilization of health-care products — Ethylene oxide — Requirements for the development, validation and rou…
Overview ISO 11135:2014 - Sterilization of health‑care products - Ethylene oxide specifies the requirements for the development, validation and routine control of an ethylene oxide (EO) sterilization…
ISO 11135:2014/Amd 1:2018
ДействующийSterilization of health-care products — Ethylene oxide — Requirements for the development, validation and rou…
Overview ISO 11135:2014/Amd 1:2018 is an important amendment to the international standard for the sterilization of health-care products using ethylene oxide. This standard outlines the requirements…
SIST EN ISO 11138-1:2017
ДействующийSterilization of health care products - Biological indicators - Part 1: General requirements (ISO 11138-1:201…
Overview EN ISO 11138-1:2017 - Sterilization of health care products - Biological indicators - Part 1: General requirements - defines the general requirements for the manufacture, labelling, testing…
SIST EN ISO 11138-2:2017
ДействующийSterilization of health care products - Biological indicators - Part 2: Biological indicators for ethylene ox…
Overview EN ISO 11138-2:2017 (CEN / ISO 11138-2:2017) defines requirements for biological indicators used to assess the performance of ethylene oxide (EO) sterilization processes for health care prod…
ISO 11737-1:2018/Amd 1:2021
ДействующийSterilization of health care products — Microbiological methods — Part 1: Determination of a population of mi…
Overview ISO 11737-1:2018/Amd 1:2021 is an important international standard focusing on the sterilization of health care products through microbiological methods. This amendment to Part 1 of ISO 1173…
SIST EN ISO 11737-2:2020
ДействующийSterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the…
Overview EN ISO 11737-2:2020 - Sterilization of health care products - Microbiological methods - Part 2 (ISO 11737-2:2019) defines general criteria for tests of sterility used when defining, validati…
ISO 10993-7:2008/Amd 1:2019
ОтменёнBiological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals — Amendment 1: Appl…
Overview ISO 10993-7:2008/Amd 1:2019 is an important amendment to the international standard focused on the biological evaluation of medical devices, specifically addressing ethylene oxide (EO) steri…
SIST EN ISO 13485:2016/A11:2021
ДействующийMedical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016)
Overview EN ISO 13485:2016/A11:2021 is the European amendment (A11) to the international standard ISO 13485:2016 specifying quality management system (QMS) requirements for medical devices. Prepared…